BAROSI, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 382
EU - Europa 357
AS - Asia 229
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 972
Nazione #
US - Stati Uniti d'America 376
CN - Cina 197
IE - Irlanda 153
IT - Italia 68
DE - Germania 41
FI - Finlandia 41
SE - Svezia 21
SG - Singapore 18
GB - Regno Unito 15
UA - Ucraina 8
CA - Canada 5
BE - Belgio 4
JP - Giappone 4
CZ - Repubblica Ceca 3
IN - India 3
IR - Iran 3
MU - Mauritius 2
PL - Polonia 2
AZ - Azerbaigian 1
BR - Brasile 1
ES - Italia 1
EU - Europa 1
KZ - Kazakistan 1
NP - Nepal 1
PA - Panama 1
UZ - Uzbekistan 1
Totale 972
Città #
Dublin 153
Chandler 120
Nanjing 46
Beijing 39
Ashburn 31
Jacksonville 27
Helsinki 24
Boardman 23
Pavia 22
Nanchang 19
New York 17
Lawrence 16
Medford 16
Princeton 16
Wilmington 14
Hangzhou 13
Shanghai 13
Changsha 12
Hebei 12
Shenyang 12
Tianjin 12
Singapore 9
Jiaxing 8
Gallarate 6
Milan 6
Toronto 5
Brussels 4
Tokyo 4
Turin 4
Augusta 3
Brno 3
Hanover 3
Jinan 3
Los Angeles 3
Rome 3
Woodbridge 3
Chicago 2
Orange 2
Piscataway 2
Polska 2
Pune 2
Santa Clara 2
Verona 2
Verrua Po 2
Washington 2
Almaty 1
Americana 1
Ann Arbor 1
Aosta 1
Ardabil 1
Baku 1
Casorate Sempione 1
Dallas 1
Esslingen am Neckar 1
Fairfield 1
Falkenstein 1
Fuzhou 1
Guangzhou 1
Kathmandu 1
Leawood 1
Modena 1
Monza 1
Munich 1
Norwalk 1
Padova 1
Redmond 1
San Francisco 1
Seattle 1
Segrate 1
Taizhou 1
Tashkent 1
Würzburg 1
Zanjan 1
Zhengzhou 1
Totale 771
Nome #
Altered fibronectin expression and deposition by myeloproliferative neoplasm-derived mesenchymal stromal cells 83
Thrombopoietin/TGF-β1 loop regulates megakaryocyte extracellular matrix component synthesis 65
Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms 65
Thrombopoietin/TGF-β1 Loop Regulates Megakaryocyte Extracellular Matrix Component Synthesis 65
The spleen of patients with myelofibrosis harbors defective mesenchymal stromal cells 65
Phenotypical, Functional and Genetic Characterization of Mesenchymal Stem Cells Derived from the Spleen of Patients with Myelofibrosis. 63
JAK2 exon 14 Skipping in Patients with Primary Myelofibrosis (PMF). 62
Splenic marginal zone cell lymphoma: report of an indolent variant without massive splenomegaly presumably representing an early phase of the disease. 58
EDA fibronectin–TLR4 axis sustains megakaryocyte expansion and inflammation in bone marrow fibrosis 54
Primary Prophylaxis of Invasive Fungal Diseases in Allogeneic Stem Cell Transplantation: Revised Recommendations from a Consensus Process by Gruppo Italiano Trapianto Midollo Osseo (GITMO) 54
SIE, SIES, GITMO evidence-based guidelines on novel agents (thalidomide, bortezomib, and lenalidomide) in the treatment of multiple myeloma 53
Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO). 52
Deciding when to intervene: a Markov decision process approach 51
Constitutive STAT5 phosphorylation in CD34+ cells of patients with primary myelofibrosis: Correlation with driver mutation status and disease severity 51
Dysregulation of VEGF-induced proangiogenic Ca(2+) oscillations in primary myelofibrosis-derived endothelial colony-forming cells 50
Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies 45
Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients with myeloproliferative neoplasms 35
Elevated plasma EDA fibronectin in primary myelofibrosis is determined by high allele burden of JAK2V617F mutation and strongly predicts splenomegaly progression 22
Increased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN-associated myelofibrosis 14
HEMATOPOIETIC PROGENITOR CELLS EXPRESSING VE-CADHERIN ARE DETECTABLE IN THE SPLEEN OF PATIENTS WITH MYELOFIBROSIS AND ARE IN CLOSE CONTACT WITH MICROVESSELS 6
Totale 1.013
Categoria #
all - tutte 4.663
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.663


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202064 0 0 0 0 0 2 13 1 7 21 18 2
2020/202160 5 1 0 11 0 4 0 12 21 5 1 0
2021/2022104 0 0 3 19 1 1 0 5 3 14 13 45
2022/2023337 34 35 3 26 29 25 2 17 153 2 7 4
2023/2024147 19 29 4 4 10 52 0 13 1 4 5 6
2024/202570 23 23 8 13 3 0 0 0 0 0 0 0
Totale 1.013